Transcept Pharmaceuticals Inc. Enters Oversold Territory - Tale of the Tape

By Zacks.com,  September 17, 2012, 10:34:39 AM EDT

Transcept Pharmaceuticals Inc. 's ( TSPT ) share price has entered into oversold territory with a stochastic value of 3.3220. The Zacks Consensus Estimate on the company's loss for year ending December 2012 decreased by 4 cents over the past two months to a loss of 71 cents per share. Transcept Pharmaceuticals Inc. is a Zacks #2 Rank ("Buy") company.

 


 
TRANSCEPT PHARM (TSPT): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: Investing, Investing Ideas, Stocks

Referenced Stocks: TSPT



Latest News Video

Private Island on the Thames: $11.7 Million
Private Island on the Thames: $11.7...
Take Control Of Your Wealth
Take Control Of Your Wealth         
How to Avoid Getting Caught Pre-Defection
How to Avoid Getting Caught Pre-Def...
WSJ House of the Week: And the Winner Is…
WSJ House of the Week: And the Winn...


Sign-in
Existing NASDAQ.com member? Log in here.

By signing into the site using any of the third-party services above, you agree to NASDAQ.com's Terms of Use.




Most Active by Volume:

Company Last Sale Change Net / %
PFE $ 29.40 0.24  0.82%
NOK $ 3.86 0.17  4.61%
S $ 7.32 0.10  1.39%
BAC $ 13.27 0.06  0.45%
GE $ 24.33 0.56  2.36%
MU $ 13.76 0.52  3.93%
SIRI $ 3.40 0.06  1.80%
MNKD $ 6.605 0.94  12.40%